IXICO PLC (LSE:IXI, OTC:PHYOF) CEO Bram Goorden explains how the company’s AI-driven neuroimaging platform is set to transform Alzheimer’s and Parkinson’s research. He outlines the Innovate, Lead, Scale strategy and how new leadership is strengthening the company's market presence.
Click the link in the video, or visit the IXICO profile to view the full interview.
#IXICO #Neuroimaging #AlzheimersResearch #ParkinsonsDisease #AIDrivenHealthcare #Biomarkers #ClinicalResearch #HealthcareInnovation #UKStocks #BramGoorden #ProactiveInvestors #MedicalAI #LifeSciences #PostMarketingSurveillance #AI #AIinHealthcare #Alzheimers #Parkinsons #BiotechInnovation